ArticleActa veterinaria Scandinavica2025
Whole-genome analysis of escherichia coli isolated from captive giant pandas (ailuropoda melanoleuca) at the Dujiangyan base of the China conservation and research center for the giant panda, Sichuan, China.
Article in Acta veterinaria Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safeguarding a Flagship Species: Integrated Surveillance of Cross-Species Pathogen Transmission in Giant Panda Ecosystems.Ecology and evolution · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The giant panda (Ailuropoda melanoleuca) is a rare and vulnerable species facing threats from bacterial infections. The extensive use of antibiotics in disease prevention has raised concerns about antibiotic resistance, which reduces treatment efficacy and poses environmental and public health risks. This study aims to analyze the resistance profiles of Escherichia coli (E. coli) in captive pandas, providing insights into the antibiotic resistance genes within their gut microbiota. Twenty-two E. coli isolates were obtained from the feces of 22 captive giant pandas, and whole-genome sequencing was conducted. Sequence types and evolutionary relationships were determined through Multi-Locus Sequence Typing (MLST) and core genome Multi-Locus Sequence Typing (cgMLST), while virulence and resistance genes were identified. Core genome SNP analysis was performed to establish genetic relationships, and AST was conducted to evaluate antibiotic resistance profiles. Whole-genome sequencing revealed 15 distinct sequence types (STs), with ST48 (22.7%, 5 isolates) and ST212 (18.2%, 4 isolates) identified as the dominant lineages. Further resolution using cgMLST revealed that ST48 encompassed multiple cgSTs distributed across different evolutionary branches, while all ST212 isolates belonged to a single cgST. These results demonstrate the utility of cgMLST in resolving genetic diversity and isolate relationships within dominant lineages. Core genome SNP-based phylogenetic analysis grouped isolates with similar serotypes and STs, including a pathogenic cluster closely related to a panda-derived E. coli isolate (AMSHJX04). A total of 88 virulence genes (average 52 per isolate) were widespread, including those involved in iron acquisition systems (yagZ/Y), fimbriae-associated genes (fimA/H), and type II secretion systems (gspM/K). Antimicrobial susceptibility testing (AST) showed 59.1% resistance to ciprofloxacin, 18.2% to norfloxacin, and 13.6% to tetracycline, while all isolates remained sensitive to gentamicin and amikacin. Resistance profiling identified 78 resistance genes, primarily efflux pumps (acrB/D, emrA/B) and tetracycline-related mutations (emrK/Y). The gut microbiota of captive giant pandas harbors multiple antibiotic resistance genes, indicating a risk of resistance gene spread. Diverse sequence types, virulence genes, and phylogenetic relationships reveal the genetic complexity of E. coli in this species. Some isolates showed genetic similarities to pathogenic E. coli, emphasizing the need for continuous bacterial monitoring. This threatens antibiotic efficacy, increases infection risks, and complicates health management, underscoring the urgency of addressing resistance in panda conservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.